Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Teodorovic

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
Human tissue research: EORTC recommendations on its practical consequencesI Teodorovic, P Therasse, A Spatz, et al.
Annals of Hematology|November 9, 2002
Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative StudyM H J Van Oers, A Hagenbeek, M Van Glabbeke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2009
Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trialP J Timmers, A H Zwinderman, I Teodorovic, et al.
Gynecologic and Obstetric Investigation|December 13, 2003
Medical fellowship programme within the Gynaecological Cancer Group of the European Organisation for Research and Treatment of CancerH C Wagenaar, J B M Z Trimbos, I Teodorovic, et al.
Environmental Science and Pollution Research International|March 24, 2009
First REP-LECOTOX Workshop-Ecotoxicogenomics: The challenge of integrating genomics/proteomics/metabolomics into aquatic and terrestrial ecotoxicologyR Kovacevic, I Teodorovic, S Kaisarevic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical featuresB Maes, A Anastasopoulou, J C Kluin-Nelemans, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2007
Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) study in 234 patientsM Franchi, J B Trimbos, F Zanaboni, et al.
Environment International|March 11, 2006
Pollution of the Begej Canal sediment--metals, radioactivity and toxicity assessmentB Dalmacija, M Prica, I Ivancev-Tumbas, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of CancerJ Raemaekers, H Kluin-Nelemans, I Teodorovic, et al.
Blood|May 15, 1996
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working FormulationS Pittaluga, L Bijnens, I Teodorovic, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
Human tissue research: EORTC recommendations on its practical consequencesI Teodorovic, P Therasse, A Spatz, et al.
Annals of Hematology|November 9, 2002
Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative StudyM H J Van Oers, A Hagenbeek, M Van Glabbeke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2009
Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trialP J Timmers, A H Zwinderman, I Teodorovic, et al.
Gynecologic and Obstetric Investigation|December 13, 2003
Medical fellowship programme within the Gynaecological Cancer Group of the European Organisation for Research and Treatment of CancerH C Wagenaar, J B M Z Trimbos, I Teodorovic, et al.
Environmental Science and Pollution Research International|March 24, 2009
First REP-LECOTOX Workshop-Ecotoxicogenomics: The challenge of integrating genomics/proteomics/metabolomics into aquatic and terrestrial ecotoxicologyR Kovacevic, I Teodorovic, S Kaisarevic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical featuresB Maes, A Anastasopoulou, J C Kluin-Nelemans, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2007
Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) study in 234 patientsM Franchi, J B Trimbos, F Zanaboni, et al.
Environment International|March 11, 2006
Pollution of the Begej Canal sediment--metals, radioactivity and toxicity assessmentB Dalmacija, M Prica, I Ivancev-Tumbas, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of CancerJ Raemaekers, H Kluin-Nelemans, I Teodorovic, et al.
Blood|May 15, 1996
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working FormulationS Pittaluga, L Bijnens, I Teodorovic, et al.
Pageof 3